These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 26586852)
1. Evaluation of combined Gd-EOB-DTPA and gadobutrol magnetic resonance imaging for the prediction of hepatocellular carcinoma grading. Schelhorn J; Best J; Dechêne A; Göbel T; Bertram S; Lauenstein T; Kinner S Acta Radiol; 2016 Aug; 57(8):932-8. PubMed ID: 26586852 [TBL] [Abstract][Full Text] [Related]
2. Therapy response assessment after radioembolization of patients with hepatocellular carcinoma--comparison of MR imaging with gadolinium ethoxybenzyl diethylenetriamine penta-acetic acid and gadobutrol. Schelhorn J; Best J; Reinboldt MP; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S J Vasc Interv Radiol; 2015 Jul; 26(7):972-9. PubMed ID: 25937296 [TBL] [Abstract][Full Text] [Related]
3. T1 mapping combined with Gd-EOB-DTPA-enhanced magnetic resonance imaging in predicting the pathologic grading of hepatocellular carcinoma. Chen CY; Chen J; Xia CC; Huang ZX; Song B J Biol Regul Homeost Agents; 2017; 31(4):1029-1036. PubMed ID: 29254310 [TBL] [Abstract][Full Text] [Related]
4. Gd-EOB-DTPA-enhanced magnetic resonance imaging combined with T1 mapping predicts the degree of differentiation in hepatocellular carcinoma. Peng Z; Jiang M; Cai H; Chan T; Dong Z; Luo Y; Li ZP; Feng ST BMC Cancer; 2016 Aug; 16():625. PubMed ID: 27520833 [TBL] [Abstract][Full Text] [Related]
5. Does diffusion-weighted imaging improve therapy response evaluation in patients with hepatocellular carcinoma after radioembolization? comparison of MRI using Gd-EOB-DTPA with and without DWI. Schelhorn J; Best J; Reinboldt MP; Dechêne A; Gerken G; Ruhlmann M; Lauenstein TC; Antoch G; Kinner S J Magn Reson Imaging; 2015 Sep; 42(3):818-27. PubMed ID: 25515676 [TBL] [Abstract][Full Text] [Related]
6. The Combination of Gd-EOB-DTPA Enhanced T1 Mapping with Apparent Diffusion Coefficient could Improve the Diagnostic Efficacy of Hepatocellular Carcinoma Grading. He H; Li X; Liu J; Tong Q; Ling M; Zeng Z; Zhou Z Curr Med Imaging; 2024; 20():e15734056259418. PubMed ID: 38918998 [TBL] [Abstract][Full Text] [Related]
7. Imaging Features of Hepatocellular Carcinoma: Quantitative and Qualitative Comparison Between MRI-Enhanced With Gd-EOB-DTPA and Gd-DTPA. Son J; Hwang SH; Park S; Han K; Chung YE; Choi JY; Kim MJ; Park MS Invest Radiol; 2019 Aug; 54(8):494-499. PubMed ID: 31094878 [TBL] [Abstract][Full Text] [Related]
8. Intra-individual comparison of hepatocellular carcinoma imaging features on contrast-enhanced computed tomography, gadopentetate dimeglumine-enhanced MRI, and gadoxetic acid-enhanced MRI. Kim YN; Song JS; Moon WS; Hwang HP; Kim YK Acta Radiol; 2018 Jun; 59(6):639-648. PubMed ID: 28825310 [TBL] [Abstract][Full Text] [Related]
9. Performance of gadoxetic acid MRI and diffusion-weighted imaging for the diagnosis of early recurrence of hepatocellular carcinoma. Rimola J; Forner A; Sapena V; Llarch N; Darnell A; Díaz A; García-Criado A; Bianchi L; Vilana R; Díaz-González Á; Ayuso C; Bruix J; Reig M Eur Radiol; 2020 Jan; 30(1):186-194. PubMed ID: 31372783 [TBL] [Abstract][Full Text] [Related]
10. Evaluation and Prognostication of Gd-EOB-DTPA MRI and CT in Patients With Macrotrabecular-Massive Hepatocellular Carcinoma. Cheng J; Li X; Wang L; Chen F; Li Y; Zuo G; Pei M; Zhang H; Yu L; Liu C; Wang J; Han Q; Cai P; Li X J Magn Reson Imaging; 2024 Jun; 59(6):2071-2081. PubMed ID: 37840197 [TBL] [Abstract][Full Text] [Related]
11. Gd-EOB-DTPA-enhanced MRI is better than MDCT in decision making of curative treatment for hepatocellular carcinoma. Yoo SH; Choi JY; Jang JW; Bae SH; Yoon SK; Kim DG; Yoo YK; Rha SE; Lee YJ; Jung ES Ann Surg Oncol; 2013 Sep; 20(9):2893-900. PubMed ID: 23649931 [TBL] [Abstract][Full Text] [Related]
12. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominantly in patients with hepatocellular carcinoma and chronic liver disease. Ichikawa T; Saito K; Yoshioka N; Tanimoto A; Gokan T; Takehara Y; Kamura T; Gabata T; Murakami T; Ito K; Hirohashi S; Nishie A; Saito Y; Onaya H; Kuwatsuru R; Morimoto A; Ueda K; Kurauchi M; Breuer J Invest Radiol; 2010 Mar; 45(3):133-41. PubMed ID: 20098330 [TBL] [Abstract][Full Text] [Related]
13. The value of Gd-EOB-DTPA-enhanced MR imaging in characterizing cirrhotic nodules with atypical enhancement on Gd-DTPA-enhanced MR images. Wang YC; Chou CT; Lin CP; Chen YL; Chen YF; Chen RC PLoS One; 2017; 12(3):e0174594. PubMed ID: 28355258 [TBL] [Abstract][Full Text] [Related]
14. Imaging features based on Gd-EOB-DTPA-enhanced MRI for predicting vessels encapsulating tumor clusters (VETC) in patients with hepatocellular carcinoma. Fan Y; Yu Y; Hu M; Wang X; Du M; Guo L; Hu C Br J Radiol; 2021 Mar; 94(1119):20200950. PubMed ID: 33417489 [TBL] [Abstract][Full Text] [Related]
15. Evolution of indeterminate hepatocellular nodules at Gd-EOB-DPTA-enhanced MRI in cirrhotic patients. Galia M; Agnello F; Sparacia G; Matranga D; Albano D; Midiri M; Lagalla R Radiol Med; 2018 Jul; 123(7):489-497. PubMed ID: 29546493 [TBL] [Abstract][Full Text] [Related]
16. Usefulness of combination of imaging modalities in the diagnosis of hepatocellular carcinoma using Sonazoid®-enhanced ultrasound, gadolinium diethylene-triamine-pentaacetic acid-enhanced magnetic resonance imaging, and contrast-enhanced computed tomography. Alaboudy A; Inoue T; Hatanaka K; Chung H; Hyodo T; Kumano S; Murakami T; Moustafa EF; Kudo M Oncology; 2011; 81 Suppl 1():66-72. PubMed ID: 22212939 [TBL] [Abstract][Full Text] [Related]
17. Comparison of Contrast-Enhanced Ultrasound and Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI for the Diagnosis of Macroscopic Type of Hepatocellular Carcinoma. Iwamoto T; Imai Y; Kogita S; Igura T; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Seki Y; Ohashi H; Fujita N; Kudo M; Takehara T Dig Dis; 2016; 34(6):679-686. PubMed ID: 27750237 [TBL] [Abstract][Full Text] [Related]
18. Gd-EOB-DTPA-enhanced magnetic resonance images of hepatocellular carcinoma: correlation with histological grading and portal blood flow. Kogita S; Imai Y; Okada M; Kim T; Onishi H; Takamura M; Fukuda K; Igura T; Sawai Y; Morimoto O; Hori M; Nagano H; Wakasa K; Hayashi N; Murakami T Eur Radiol; 2010 Oct; 20(10):2405-13. PubMed ID: 20490505 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the performance of hepatobiliary agents in depicting MRI features of microvascular infiltration in hepatocellular carcinoma. Yao WW; Zhang HW; Ma YP; Lee JM; Lee RT; Wang YL; Liu XL; Shen XP; Huang B; Lin F Abdom Radiol (NY); 2024 Jul; 49(7):2242-2249. PubMed ID: 38824474 [TBL] [Abstract][Full Text] [Related]
20. Health economic evaluation of Gd-EOB-DTPA MRI vs ECCM-MRI and multi-detector computed tomography in patients with suspected hepatocellular carcinoma in Thailand and South Korea. Lee JM; Kim MJ; Phongkitkarun S; Sobhonslidsuk A; Holtorf AP; Rinde H; Bergmann K J Med Econ; 2016 Aug; 19(8):759-68. PubMed ID: 27026278 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]